Alimera Sciences specializes in developing and selling ophthalmic pharmaceuticals, including ILUVIEN, an implant used in the treatment of diabetic macular edema. Their products are distributed directly to physician offices, pharmacies, and hospitals. The company has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. to expand its offerings.